1 A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

2 Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial

3 Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration

4 Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

5 Efficacy and safety of recombinant human activated protein C for severe sepsis

6 Prophylactic antibiotics in common dog bite wounds: a controlled study

7 Ribavirin aerosol for acute bronchiolitis

8 A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

9 Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial

10 Prophylactic oxacillin in dog bite wounds

11 Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated Chlamydial urethritis and cervicitis. Trovafloxacin Chlamydial Urethritis/Cervicitis Study Group

12 Treatment of cutaneous abscess: a double-blind clinical study

13 Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial

14 Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes

15 Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

16 A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection

17 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual

18 Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection

19 Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy

20 Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60

21 Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease

22 Iron supplementation in HIV-infected Malawian children with anemia: a double-blind, randomized, controlled trial

23 Telaprevir for previously untreated chronic hepatitis C virus infection

24 Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial

25 Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient

26 Loperamide in the treatment of acute gastroenteritis in early childhood. Report of a two centre, double-blind, controlled clinical trial

27 A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

28 A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men

29 A multicenter randomized controlled trial of a liquid loperamide product versus placebo in the treatment of acute diarrhea in children

30 Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection

31 A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection

32 A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease

33 Prophylactic and preventive antibiotic therapy: timing, duration and economics

34 Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial

35 Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes

36 The value of adjuvant systemic antibiotic therapy in localised wound infections among hospital patients: a comparative study

37 Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment

38 The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447]

39 Effect of spectacle lenses designed to reduce relative peripheral hyperopia on myopia progression in Japanese children: a 2-year multicenter randomized controlled trial

40 Efficacy and safety of azithromycin versus lymecyline in the treatment of genital chlamydial infections in women

41 Loperamide for treatment of acute diarrhoea in infants and young children. A double-blind placebo-controlled trial

42 Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

43 Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh

44 Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease

45 Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection

46 Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

47 Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial

48 Vedolizumab as induction and maintenance therapy for ulcerative colitis

49 Penicillin to prevent recurrent leg cellulitis

50 Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia

51 Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group

52 A comparative double blind study of amoxycillin/clavulanate vs placebo in the prevention of infection after animal bites

53 Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

54 Boceprevir for untreated chronic HCV genotype 1 infection

55 Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in Marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial

56 A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

57 Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement

58 Spread fortified with vitamins and minerals induces catch-up growth and eradicates severe anemia in stunted refugee children aged 3-6 y

59 Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

60 Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis

61 The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double-blind, placebo-controlled trial in Uganda

62 Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants

63 Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study

64 Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine

65 Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

66 Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial

67 Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial

68 Early ribavirin treatment of respiratory syncytial viral infection in high-risk children

69 Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

70 Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease

71 Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

72 A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)

73 Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

74 High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women

75 Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease

76 Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

77 Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

78 Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis

79 Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial

80 Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial

81 Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects

82 Continuous lenalidomide treatment for newly diagnosed multiple myeloma

83 Fidaxomicin versus vancomycin for Clostridium difficile infection

84 Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

85 A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease

86 Titrated baclofen for high-risk alcohol consumption: a randomized placebo-controlled trial in out-patients with 1-year follow-up

87 Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC

88 ACE inhibitor and swallowing reflex

89 Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults

90 A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial

91 Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial

92 Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers

93 Oral oseltamivir treatment of influenza in children

94 Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial

95 Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

96 Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction

97 Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed

98 Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

99 Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial

100 Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial

101 Salicylates, oligoantigenic diets, and behaviour

Keyword Connections

Journals

Research Groups

Bibliographies